Trixeo Aerosphere receives positive EU CHMP opinion as first inhaled medicine with near-zero GWP
Trixeo is the first pMDI medicine in AstraZeneca’s portfolio to use the near-zero GWP propellant
Trixeo is the first pMDI medicine in AstraZeneca’s portfolio to use the near-zero GWP propellant
This case report is jointly authored by US clinicians from leading hospitals, Houston Methodist Hospital, Weill Cornell Medical College and Johns Hopkins
Combined strength of two brands across 11 states to elevate patient care delivery and access to doctors
Neuberg group commits to invest over Rs. 100 crores to start diagnostics facilities across Jharkhand in the next 2-3 years
Aims to support healthcare practitioners with evidence-based cough categorization tools that enable choosing the right molecules for effective & targeted relief from cough
India’s fertility rate has dropped to 1.9, below the replacement level of 2.1
First pivotal Phase 3 trial to show superiority of Keytruda plus a TROP2 antibody-drug conjugate, Trodelvy, versus standard of care in first-line metastatic TNBC
The initiative was announced at World Hypertension Congress, Chennai
The 27 greenfield labs across the country ensure timely and accurate reporting
The new facility combines advanced technology, enhanced capacity, and holistic care, reaffirming HCG’s commitment to accessible, world-class oncology in Gujarat
Subscribe To Our Newsletter & Stay Updated